Literature DB >> 14769836

Eye-preservation treatment of retinoblastoma with vitreous seeding.

Akihiro Kaneko1, Shigenobu Suzuki.   

Abstract

Retinoblastoma with vitreous seeding has been one of the most challenging conditions for eye-preservation therapy. Several modalities for treating vitreous seeding were reviewed in order to analyze the problems associated with them. External beam radiotherapy has been the most reliable method to treat vitreous seeding. However, recurrence after external beam radiotherapy needs other types of treatments to preserve the eyeballs. Due to the progress of investigations concerning retinoblastoma, chemotherapy has become the most promising method to cure not only recurrence but also primary tumors. Systemic chemotherapy can rarely cure vitreous seeding, but local chemotherapy using vitreous injections of melphalan can preserve about 50% of the eyeballs with vitreous seeding. Currently, animal experiments are being conducted to study the efficacy and safety of vitreous surgery combined with infusion of anticancer drugs for eradication of vitreous seeds and maintenance of visual function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769836

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  41 in total

1.  Clinicopathological investigation of a retinoblastoma eye enucleated after vitreous surgery with melphalan perfusion.

Authors:  Koh-Ichi Ohshima; Taku Kaneko; Seiji Takagi; Akihiro Kaneko; Yuki Yokouchi; Shinobu Takeuchi
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

2.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

3.  [New therapeutic strategies for retinoblastoma: non-systemic chemotherapy].

Authors:  E Biewald; M Holdt; N Bornfeld
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

4.  Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity.

Authors:  Hassan A Aziz; Jonathan W Kim; Francis L Munier; Jesse L Berry
Journal:  Ocul Oncol Pathol       Date:  2016-09-14

Review 5.  Management of retinoblastoma in children: current status.

Authors:  Guillermo Chantada; Paula Schaiquevich
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

6.  Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.

Authors:  Jasmine H Francis; Larissa A Habib; David H Abramson
Journal:  Adv Ophthalmol Optom       Date:  2017-08

7.  Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma.

Authors:  Jasmine H Francis; Christopher A Barker; Suzanne L Wolden; Beryl McCormick; Kira Segal; Gil Cohen; Y Pierre Gobin; Brian P Marr; Scott E Brodie; Ira J Dunkel; David H Abramson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-14       Impact factor: 7.038

Review 8.  The management of retinoblastoma.

Authors:  Ido D Fabian; Zerrin Onadim; Esin Karaa; Catriona Duncan; Tanzina Chowdhury; Irene Scheimberg; Shin-Ichi Ohnuma; M Ashwin Reddy; Mandeep S Sagoo
Journal:  Oncogene       Date:  2018-01-11       Impact factor: 9.867

9.  Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.

Authors:  David H Abramson; Xunda Ji; Jasmine H Francis; Federica Catalanotti; Scott E Brodie; Larissa Habib
Journal:  Br J Ophthalmol       Date:  2018-06-06       Impact factor: 4.638

Review 10.  Focal laser treatment in addition to chemotherapy for retinoblastoma.

Authors:  Ido D Fabian; Kenneth P Johnson; Andrew W Stacey; Mandeep S Sagoo; M A Reddy
Journal:  Cochrane Database Syst Rev       Date:  2017-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.